(Q48309963)

10 February 2018

title

Effects of inhibition of ornithine aminotransferase on thioacetamide-induced hepatogenic encephalopathy. (English)

1 reference

10 February 2018

author name string

S Sarhan

1

1 reference

10 February 2018

B Knödgen

2

1 reference

10 February 2018

C Grauffel

3

1 reference

10 February 2018

N Seiler

4

1 reference

10 February 2018

publication date

1 April 1993

1 reference

10 February 2018

published in

Neurochemical Research

1 reference

10 February 2018

volume

18

1 reference

10 February 2018

issue

4

1 reference

10 February 2018

page(s)

539-549

1 reference

10 February 2018

https://scigraph.springernature.com/pub.10.1007/bf00967259

exact match

0 references

cites work

Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: characterization of an improved model and study of amino acid-ergic neurotransmission

1 reference

12 December 2020

Metabolic inhibitors and subcellular distribution of GABA

1 reference

12 December 2020

4-Aminobutyrate in mammalian putrescine catabolism

1 reference

12 December 2020

A simple device for measuring exploratory activity and motility in mice (author's transl)

1 reference

12 December 2020

PURIFICATION AND PROPERTIES OF RAT LIVER ORNITHINE DELTA-TRANSAMINASE

1 reference

12 December 2020

omega-Fluoromethyl analogues of omega-amino acids as irreversible inhibitors of 4-aminobutyrate:2-oxoglutarate aminotransferase

1 reference

12 December 2020

Effect of acute thioacetamide administration on rat brain phospholipid metabolism

1 reference

12 December 2020

Amino acid disturbances in liver failure

1 reference

12 December 2020

Developmental changes of putreanine in vertebrate brains.

1 reference

12 December 2020

Synergistic anticonvulsant effects of GABA-T inhibitors and glycine.

1 reference

12 December 2020

Brain histology and behavior of mice injected with urease

1 reference

12 December 2020

A simple and sensitive fluorescence assay for monoamine oxidase and diamine oxidase.

1 reference

12 December 2020

Thioacetamide-induced hepatic encephalopathy in the rat. I. Preliminary morphological and biochemical observations

1 reference

12 December 2020

The use of ornithine salts of branched-chain ketoacids in portal-systemic encephalopathy

1 reference

12 December 2020

Induction of two different modes of cell death, apoptosis and necrosis, in rat liver after a single dose of thioacetamide

1 reference

12 December 2020

Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure

1 reference

12 December 2020

Regulation of glutamine synthetase in cultured 3T3-L1 cells by insulin, hydrocortisone, and dibutyryl cyclic AMP

1 reference

12 December 2020

Interrelationships between ornithine, glutamate and GABA-I. Feed-back inhibition of ornithine aminotransferase by elevated brain GABA levels

1 reference

12 December 2020

Ornithine aminotransferase activity, liver ornithine concentration and acute ammonia intoxication

1 reference

12 December 2020

Plasma and Brain Amino Acids in Fulminant Hepatic Failure and their Relationship to Hepatic Encephalopathy

1 reference

12 December 2020

Soluble gamma-aminobutyric-glutamic transaminase from Pseudomonas fluorescens

1 reference

12 December 2020

Cerebrospinal fluid content of diazepam binding inhibitor in chronic hepatic encephalopathy.

1 reference

12 December 2020

Visual evoked potentials in a rabbit model of hepatic encephalopathy. I. Sequential changes and comparisons with drug-induced comas.

1 reference

12 December 2020

The use of inhibitors of GABA-transaminase for the determination of GABA turnover in mouse brain regions: an evaluation of aminooxyacetic acid and gabaculine.

1 reference

12 December 2020

DL-canaline and 5-fluoromethylornithine. Comparison of two inactivators of ornithine aminotransferase

1 reference

12 December 2020

Metabolism and toxicity of ammonia

1 reference

12 December 2020

Interrelationships between ornithine, glutamate and GABA-III. An ornithine aminotransferase activity that is resistant to inactivation by 5-fluoromethylornithine.

1 reference

12 December 2020

Plasma and brain tryptophan changes in experimental acute hepatic failure

1 reference

12 December 2020

Brain concentrations of benzodiazepines are elevated in an animal model of hepatic encephalopathy

1 reference

12 December 2020

Arginine in thioacetamide-induced hepatogenic encephalopathy in rats: activation of enzymes of arginine metabolism to glutamate.

1 reference

12 December 2020

The pathogenesis and treatment of hepatic encephalopathy: evidence for the involvement of benzodiazepine receptor ligands

1 reference

12 December 2020

Neurochemistry of hepatic encephalopathy

1 reference

12 December 2020

Reversal of the behavioral and electrophysiological abnormalities of an animal model of hepatic encephalopathy by benzodiazepine receptor ligands

1 reference

12 December 2020

5-Fluoromethylornithine, an irreversible and specific inhibitor of L-ornithine:2-oxo-acid aminotransferase

1 reference

12 December 2020

Inhibition of Ornithine Aminotransferase by 5-Fluoromethylornithine: Protection Against Acute Thioacetamide Intoxication by Elevated Tissue Ornithine Levels

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00967259

1 reference

10 February 2018

1 reference

10 February 2018